Mohd Zulkefeli Bin Mat Jusoh
International Medical University, Universiti Teknologi MARA, Hiroshima University
About
Prof. Dr Mohd Zulkefeli bin Mat Jusoh B.Pharm.Sc (Hiroshima), M.Pharm.Sc (Hiroshima), PhD (Hiroshima), RPh
Dr Mohd Zulkefeli, PhD is the Immediate Past Dean of the School of Pharmacy and was promoted to full professorship in 2022, where he was an Associate Professor of the Pharmaceutical Chemistry Department at International Medical University (IMU) since September 2016. Before joining the IMU, he was a Senior Lecturer in the Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) and had served in various administrative positions including Deputy Dean of Academic, Quality and Research (2007 to 2008) and Deputy Dean of Research and Industrial Linkages (2011 to 2012). He was also a Director of the Centre of Excellence for Natural Products Discovery Research (2012 until 2014).
He was among the first group of Malaysians who graduated with the BPharmSc, from Hiroshima University, Japan in 1998 with a Scholarship of Public Service Department and later completed his postgraduate studies, MPharmSc (By Research) in 2002, and PhD in 2005, at Hiroshima University, Japan under a Scholarship of MONBUSHO (Japanese Government).
Dr Zulkefeli spent two years as a post-doctoral researcher with a fellowship under the Japan Society for The Promotion of Science (JSPS) in Tokyo University of Science (TUS), Japan from 2008 until 2010, and a post-doctoral researcher under NanoMalaysia-IBM Research Collaboration Program, at IBM Research-Almaden, San Jose, California, the USA from 2014 until 2015. He received his Full-registered Pharmacist status in 2013.
He also obtained several national research grants such as MAKNA Cancer Research Award (2005), Biotech Incentive MOSTI (2006), and FRGS (2014). His research interests include Supramolecular Chemistry (Design and Synthesis of Functionalities Supramolecules by Self-Assembly method in Aqueous Solution) and Medicinal Chemistry (Design and Synthesis of Bioactive Molecules) and Pharmaceutical Chemistry Education. His research output has been translated into a few high-impact publications, such as articles in PNAS, JACS and Inorganic Chemistry (ACS journals), a patent and also a chapter in a research book.
Dr Zulkefeli also actively serve as a panel member for the accreditation of pharmaceutical science-related programmes under the Malaysian Qualifications Agency (MQA). He is also an immediate past minister-appointed member of the Pharmacy Board Malaysia and a principal of the Malaysian Academy of Pharmacy.
Employment
-
International Medical University Director of Quality IMU/Professor of Pharmaceutical Chemistry2016 - Present
-
Universiti Teknologi MARA Senior Lecturer2005 - 2008
Education
-
Hiroshima University
Projects & Funding
Projects & funding information is unavailable.
Publications (23)
- Arginine-Tryptophan Peptides Enhancing Antibacterial and Anticancer Effects of Ruthenium(II) Polypyridyl Complex Photosensitizers Save
- Novel ruthenium(II) polypyridyl complexes conjugated with bis-dipicolylamine as antibacterial photosensitisers Save
- Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms Save
- Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability Save
- Co-Encapsulation of Gemcitabine and Tocotrienols in Nanovesicles Enhanced Efficacy in Pancreatic Cancer Save
- Studies on the mechanism of anti-inflammatory action of swietenine, a tetranortriterpenoid isolated from Swietenia macrophylla seeds Save
- Pharmacy education during and beyond COVID-19 in six Asia-Pacific countries: Changes, challenges, and experiences Save
- Development of metallosupramolecular phosphatases based on the combinatorial self-assembly of metal complexes and organic building blocks for the catalytic hydrolysis of phosphate monoesters Save
- Polymer-wrapped single-walled carbon nanotubes: a transformation toward better applications in healthcare Save
- Challenges and opportunities of nanotechnology as delivery platform for tocotrienols in cancer therapy Save